Steven C. Quay Explained

Steven C. Quay is an American author, scientist, and businessman. He is the current chief executive officer (CEO) of Atossa Therapeutics.^[1]

Biography

Quay received his education from the University of Michigan Medical School and completed his doctorate in 1975.^[2] Quay worked as a postdoctoral fellow with Nobel Laureate Har Gobind Khorana at MIT.^[3] He has previously worked as a faculty member of Department of Pathology, Stanford University School of Medicine.^[4]

In 2009, Quay founded Atossa Therapeutics, a biopharmaceutical company based in Seattle.^[1] The company is listed on Nasdaq since 2012.^[5]

In September 2021, Quay published a book, The Origin of the Virus: The hidden truths behind the microbe that killed millions of people, along with Angus Dalgleish and Paolo Barnard.^[6] He is also an author of a book named Stay Safe: A Physician's Guide to Survive Coronavirus.

Bibliography

Books

• Book: Quay . Steven . Chen . Shu Chih . Nipple Aspirate Fluid Exfoliative Cytopathology and Molecular Biomarkers: Current Role in the Management of Breast Health . 2016 . Atossa Genetics . 978-0-9968496-2-3 .
• Book: Barnard . Paolo . Quay . Steven . Dalgleish . Angus . The Origin of the Virus: The Hidden Truths Behind the Microbe That Killed Millions of People . 2021 . Clinical Press Limited . 978-1-85457-106-9 .

Publications

• Daniels . C. J. . Bole . D. G. . Quay . S. C. . Oxender . D. L. . Role for membrane potential in the secretion of protein into the periplasm of Escherichia coli. . Proceedings of the National Academy of Sciences . September 1, 1981 . 78 . 9 . 5396–5400 . 10.1073/pnas.78.9.5396 . 7029533 . 348752 . 1981PNAS...78.5396D . free .
• Dvorak . H. F. . Quay . S. C. . Orenstein . N. S. . Dvorak . A. M. . Hahn . P. . Bitzer . A. M. . Carvalho . A. C. . Tumor Shedding and Coagulation . Science . May 22, 1981 . 212 . 4497 . 923–924 . 10.1126/science.7195067 . 7195067 . 1981Sci...212..923D .
• Re . Richard . Fallon . John T. . Dzau . Victor . Quay . Steven C. . Haber . Edgar . Renin synthesis by canine aortic smooth muscle cells in culture . Life Sciences . January 1982 . 30 . 1 . 99–106 . 10.1016/0024-3205(82)90641-5 . 7033709 .
• Rocklage . Scott M. . Cacheris . William P. . Quay . Steven C. . Hahn . F. Ekkehardt . Raymond . Kenneth N. . Manganese(II) N,N'-dipyridoxylethylenediamine-N,N'-diacetate 5,5'-bis(phosphate). Synthesis and characterization of a paramagnetic chelate for magnetic resonance imaging enhancement . Inorganic Chemistry . February 1989 . 28 . 3 . 477–485 . 10.1021/ic00302a019 .
• Cacheris . William P. . Quay . Steven C. . Rocklage . Scott M. . The relationship between thermodynamics and the toxicity of gadolinium complexes . Magnetic Resonance Imaging . January 1990 . 8 . 4 . 467–481 . 10.1016/0730-725x(90)90055-7 . 2118207 .
• Elizondo . G . Fretz . C J . Stark . D D . Rocklage . S M . Quay . S C . Worah . D . Tsang . Y M . Chen . M C . Ferrucci . J T . Preclinical evaluation of MnDPDP: new paramagnetic hepatobiliary contrast agent for MR imaging. . Radiology . January 1991 . 178 . 1 . 73–78 . 10.1148/radiology.178.1.1898538 . 1898538 .
• Lim . K O . Stark . D D . Leese . P T . Pfefferbaum . A . Rocklage . S M . Quay . S C . Hepatobiliary MR imaging: first human experience with MnDPDP. . Radiology . January 1991 . 178 . 1 . 79–82 . 10.1148/radiology.178.1.1898539 . 1898539 .
• Costantino . Henry R. . Illum . Lisbeth . Brandt . Gordon . Johnson . Paul H. . Quay . Steven C. . Intranasal delivery: Physicochemical and therapeutic aspects . International Journal of Pharmaceutics . June 2007 . 337 . 1–2 . 1–24 . 10.1016/j.ijpharm.2007.03.025 . 17475423 .

Notes and References

1. Web site: Seattle biotech Atossa Therapeutics eyes acquisition of unnamed company.
2. Web site: Steven Quay. June 21, 2016.
3. Web site: Steven Quay.
4. News: Letter Seeking International Inquiry Into Origins of the Coronavirus . The New York Times . March 4, 2021 .
5. Web site: Sinking stock threatens Atossa's place on the Nasdaq.
6. News: Sadar . Anthony J. . BOOK REVIEW: 'The Origin of the Virus' . The Washington Times . October 28, 2021 .